表紙
市場調查報告書

傷口縫合設備:醫療設備的開發平台評估

Wound Closure Devices - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 579981
出版日期 內容資訊 英文 610 Pages
訂單完成後即時交付
價格
Back to Top
傷口縫合設備:醫療設備的開發平台評估 Wound Closure Devices - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月15日內容資訊: 英文 610 Pages
簡介

本報告提供傷口縫合設備的開發中產品的相關調查,提供產品開發·臨床實驗的整體進展,及企業·各產品詳細趨勢(臨床實驗的進展,開始/結束時期,核准預測等),總括性彙整近幾年的開發·資本交易趨勢等資訊。

第1章 目錄

第2章 簡介

  • 傷口縫合設備概要

第3章 傷口縫合設備-開發中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:審查各級
  • 開發中產品:各預定核准時期
  • 現在進行中的臨床實驗

第4章 傷口縫合設備-正在開發的開發中產品:各企業

  • 傷口縫合設備企業:各開發階段的開發中產品
  • 傷口縫合設備:各開發階段的開發中產品

第5章 傷口縫合設備:企業及產品概要

  • 3-D Matrix Ltd
  • Actamax Surgical Materials LLC
  • Adhesys Medical GmbH
  • Advanced Medical Solutions Group plc
  • Alafair Biosciences Inc
  • Alumend LLC Company
  • Anika Therapeutics Inc
  • Arch Therapeutics Inc
  • Argon Medical Devices Inc
  • Aura Medsystems, Inc.
  • Baxter International Inc
  • Bayer HealthCare AG
  • Bergen Medical Products Inc
  • Beth Israel Deaconess Medical Center Inc
  • Biomedica Management Corp
  • Biom'Up SAS
  • Boston University
  • C. R. Bard Inc
  • Calmare Therapeutics Inc
  • CardioCommand Inc
  • Cellphire Inc
  • Ceramicos Para Aplicacoes Medicas Lda
  • Clemson University
  • Cohera Medical Inc
  • Columbia University
  • CorMedix Inc
  • Covalent Medical, Inc.
  • Covalon Technologies Ltd
  • Cresilon Inc
  • CryoLife Inc
  • CSMG Technologies, Inc.
  • Daewoong Pharmaceutical Co Ltd
  • Dermtreat ApS
  • DSM Biomedical BV
  • Emory University
  • Endomedix Incorporated
  • Entegrion Inc
  • Ethicon Endo-Surgery Inc
  • Ethicon US LLC
  • Gamma Therapeutics Inc
  • Gecko Biomedical
  • gel-e Inc
  • Grifols SA
  • Haemostatix Ltd
  • Hemostasis LLC
  • HyperBranch Medical Technology Inc
  • Innocoll Technologies Ltd
  • Institute of Molecular Biology of Parana
  • Integra LifeSciences Holdings Corp
  • InVivo Therapeutics Corp
  • IonMed Ltd.
  • John Hopkins University
  • KeraNetics, LLC
  • Kitotech Medical, Inc.
  • Kollodis BioSciences Inc
  • Kuros Biosciences AG
  • Kytogenics Pharmaceuticals Inc
  • Laser Tissue Welding, Inc.
  • Latch Medical Ltd
  • Lenvitz Medical Solutions Pvt. Ltd.
  • Life Care Medical Devices Limited
  • LifeBond Ltd
  • Maxigen Biotech Inc
  • Medisse BV
  • Medtronic plc
  • MLM Biologics Inc
  • Northwestern University
  • OptMed, Inc.
  • PetVivo Holdings Inc
  • Pharming Group NV
  • Polyganics BV
  • Protein Polymer Technologies Inc
  • Regenics AS
  • Resorba GmbH
  • Resultados y Calidad del Sistema Sanitario Publico de Andalucia
  • Rice University
  • Samyang Biopharmaceuticals Corp
  • Sanofi
  • Sea Run Holdings Inc
  • Sealantis Ltd.
  • Seraffix Ltd
  • Shanghai Haohai Biological Technology Co Ltd
  • Sheba Medical Center
  • St Teresa Medical Inc
  • Surgical Energetics LLC
  • Surgical Sealants, Inc.
  • TEIJIN FIBERS製藥
  • Texas A&M University
  • The Medicines Company
  • ThermoTek, Inc.
  • Therus Corporation
  • Thrombotargets Corp
  • Tribos LLC
  • Tricol Biomedical Inc
  • United Health Products, Inc.
  • University of Akron
  • University of Grenoble Alpes
  • University of Kansas
  • University of Toledo
  • Vigor Medical Technologies Ltd.
  • Virginia Commonwealth University
  • Wound Management Technologies Inc
  • WoundZipper Inc
  • Xcede Technologies Inc

第6章 傷口縫合設備:近幾年趨勢

第7章 附錄

  • 調查手法
  • 關於GlobalData
  • 聯絡處
  • 免責聲明

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0836EPD

GlobalData's Medical Devices sector report, "Wound Closure Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Wound Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Wound Closure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Wound Closure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Wound Closure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Wound Closure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1 List of Tables 15
  • 1.2 List of Figures 28

2 Introduction 29

  • 2.1 Wound Closure Devices Overview 29

3 Products under Development 32

  • 3.1 Wound Closure Devices - Pipeline Products by Stage of Development 32
  • 3.2 Wound Closure Devices - Pipeline Products by Segment 33
  • 3.3 Wound Closure Devices - Pipeline Products by Territory 35
  • 3.4 Wound Closure Devices - Pipeline Products by Regulatory Path 36
  • 3.5 Wound Closure Devices - Pipeline Products by Estimated Approval Date 37
  • 3.6 Wound Closure Devices - Ongoing Clinical Trials 38

4 Wound Closure Devices - Pipeline Products under Development by Companies 39

  • 4.1 Wound Closure Devices Companies - Pipeline Products by Stage of Development 39
  • 4.2 Wound Closure Devices - Pipeline Products by Stage of Development 45

5 Wound Closure Devices Companies and Product Overview 51

6 Wound Closure Devices- Recent Developments 299

7 Appendix 595

List of Tables

  • Table 1: Wound Closure Devices - Pipeline Products by Stage of Development 32
  • Table 2: Wound Closure Devices - Pipeline Products by Segment 33
  • Table 3: Wound Closure Devices - Pipeline Products by Territory 35
  • Table 4: Wound Closure Devices - Pipeline Products by Regulatory Path 36
  • Table 5: Wound Closure Devices - Pipeline Products by Estimated Approval Date 37
  • Table 6: Wound Closure Devices - Ongoing Clinical Trials 38
  • Table 7: Wound Closure Devices Companies - Pipeline Products by Stage of Development 39
  • Table 8: Wound Closure Devices - Pipeline Products by Stage of Development 45
  • Table 9: 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 10: PuraStat Hemostat - Product Status 52
  • Table 11: PuraStat Hemostat - Product Description 52
  • Table 12: TDM-511 - Product Status 53
  • Table 13: TDM-511 - Product Description 53
  • Table 14: TDM-623 - Product Status 53
  • Table 15: TDM-623 - Product Description 54
  • Table 16: TDM-651 - Product Status 54
  • Table 17: TDM-651 - Product Description 54
  • Table 18: 3-D Matrix Ltd - Ongoing Clinical Trials Overview 55
  • Table 19: PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of Purastat Absorbable Haemostatic Material for the Management of Bleeding after Open Liver Resection 56
  • Table 20: PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery 56
  • Table 21: PuraStat Hemostat - A Multicenter Prospective Observational Study to Evaluate the Utilization, Effectiveness and Safety of Purastat in the Management of Gastrointestinal Bleeding 57
  • Table 22: PuraStat Hemostat - The Hemostatic Potential of TDM-621 on Ascending Aortic Surgery 57
  • Table 23: ACell Inc Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 24: MicroMatrix - Product Status 58
  • Table 25: MicroMatrix - Product Description 58
  • Table 26: ACell Inc - Ongoing Clinical Trials Overview 59
  • Table 27: MicroMatrix - A Single Site Randomized, Clinical Trial Comparing the Concomitant Use of MicroMatrix with Cytal Wound Matrix 2-Layer to Standard of Care in Patients with Stage 3 or 4 Pressure Injuries 60
  • Table 28: MicroMatrix - The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series 60
  • Table 29: MicroMatrix - Use of Cytal Wound Matrix and MicroMatrix for the Management of Wounds 60
  • Table 30: Actamax Surgical Materials LLC Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 31: Actamax Adhesion Barrier - Product Status 61
  • Table 32: Actamax Adhesion Barrier - Product Description 61
  • Table 33: Actamax Surgical Materials LLC - Ongoing Clinical Trials Overview 62
  • Table 34: Actamax Adhesion Barrier - A Randomized, Controlled, Multi-center Study to Assess the Safety and Efficacy of Actamax Adhesion Barrier in Women undergoing Laparoscopic Abdominopelvic Surgery with a Myomectomy Followed by Second Look Laparoscopy (SLL) 63
  • Table 35: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 36: CUTIS - Product Status 64
  • Table 37: CUTIS - Product Description 64
  • Table 38: VIVO - Product Status 65
  • Table 39: VIVO - Product Description 65
  • Table 40: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 41: Large Wounds Closure Device - Product Status 66
  • Table 42: Large Wounds Closure Device - Product Description 66
  • Table 43: LiquiBand - Product Status 67
  • Table 44: LiquiBand - Product Description 67
  • Table 45: LiquiBand Exceed - Product Status 67
  • Table 46: LiquiBand Exceed - Product Description 68
  • Table 47: LiquiBand Flow Control - Product Status 68
  • Table 48: LiquiBand Flow Control - Product Description 68
  • Table 49: Next Generation Internal Fixation And Sealant Device - Product Status 69
  • Table 50: Next Generation Internal Fixation And Sealant Device - Product Description 69
  • Table 51: Advanced Medical Solutions Group plc - Ongoing Clinical Trials Overview 70
  • Table 52: LiquiBand Exceed - Trial Investigating Cyanoacrylate Glue to Prevent Surgical Site Infection Following Breast Surgery 71
  • Table 53: AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 54: Rivelin Plain Patch - Product Status 72
  • Table 55: Rivelin Plain Patch - Product Description 72
  • Table 56: Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 57: VersaWrap Adhesion Barrier - Product Status 73
  • Table 58: VersaWrap Adhesion Barrier - Product Description 73
  • Table 59: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 60: Biohybrid Membrane - Product Status 74

List of Figures

  • Figure 1: Wound Closure Devices - Pipeline Products by Stage of Development 32
  • Figure 2: Wound Closure Devices - Pipeline Products by Segment 33
  • Figure 3: Wound Closure Devices - Pipeline Products by Territory 35
  • Figure 4: Wound Closure Devices - Pipeline Products by Regulatory Path 36
  • Figure 5: Wound Closure Devices - Pipeline Products by Estimated Approval Date 37
  • Figure 6: Wound Closure Devices - Ongoing Clinical Trials 38
Back to Top